Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
323.50 EUR | +0.15% |
|
+1.73% | +2.21% |
Jun. 19 | Virbac SA Appoints Paul Martingell as Chief Executive Officer, Effective September 1, 2025 | CI |
Jun. 19 | France's Virbac Names New CEO | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.35 | 9.24 | 9.06 | 8.34 | 8.66 | |||||
Return on Total Capital | 8.65 | 13.38 | 13.05 | 11.82 | 11.99 | |||||
Return On Equity % | 23.45 | 16.76 | 15.51 | 13.84 | 14.93 | |||||
Return on Common Equity | 24.1 | 16.82 | 15.59 | 13.94 | 14.95 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 66.11 | 67 | 65.37 | 65.2 | 67.36 | |||||
SG&A Margin | 46.8 | 46.49 | 45.83 | 45.95 | 46.19 | |||||
EBITDA Margin % | 17.27 | 19.18 | 17.95 | 17.81 | 19.64 | |||||
EBITA Margin % | 14.71 | 16.96 | 15.91 | 15.7 | 17.25 | |||||
EBIT Margin % | 13.24 | 16.06 | 15.1 | 14.92 | 16.39 | |||||
Income From Continuing Operations Margin % | 15.18 | 10.87 | 9.98 | 9.71 | 10.43 | |||||
Net Income Margin % | 14.71 | 10.64 | 10.03 | 9.73 | 10.4 | |||||
Net Avail. For Common Margin % | 14.71 | 10.64 | 10.03 | 9.73 | 10.4 | |||||
Normalized Net Income Margin | 7.14 | 9.31 | 9.36 | 8.87 | 9.81 | |||||
Levered Free Cash Flow Margin | 9.89 | 6.93 | 2.85 | 4.24 | 5.04 | |||||
Unlevered Free Cash Flow Margin | 10.61 | 7.28 | 3.04 | 4.69 | 5.54 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.77 | 0.92 | 0.96 | 0.89 | 0.85 | |||||
Fixed Assets Turnover | 3.75 | 4.3 | 4.58 | 4.33 | 3.8 | |||||
Receivables Turnover (Average Receivables) | 9.29 | 10.18 | 9.59 | 7.94 | 7.68 | |||||
Inventory Turnover (Average Inventory) | 1.52 | 1.46 | 1.4 | 1.29 | 1.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.83 | 1.68 | 1.85 | 1.93 | 1.82 | |||||
Quick Ratio | 1.13 | 0.93 | 0.97 | 1.05 | 0.91 | |||||
Operating Cash Flow to Current Liabilities | 0.39 | 0.35 | 0.25 | 0.3 | 0.44 | |||||
Days Sales Outstanding (Average Receivables) | 39.39 | 35.86 | 38.06 | 46 | 47.68 | |||||
Days Outstanding Inventory (Average Inventory) | 241.36 | 250.2 | 260.51 | 282.06 | 298.43 | |||||
Average Days Payable Outstanding | 106.35 | 99.67 | 98.24 | 113.66 | 99.33 | |||||
Cash Conversion Cycle (Average Days) | 174.4 | 186.39 | 200.34 | 214.4 | 246.79 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 17.9 | 13.52 | 11.54 | 13.44 | 29.98 | |||||
Total Debt / Total Capital | 15.18 | 11.91 | 10.35 | 11.85 | 23.07 | |||||
LT Debt/Equity | 11.94 | 5.99 | 5.41 | 7.21 | 23.41 | |||||
Long-Term Debt / Total Capital | 10.13 | 5.27 | 4.85 | 6.36 | 18.01 | |||||
Total Liabilities / Total Assets | 40.87 | 39.65 | 37.08 | 37.49 | 43.55 | |||||
EBIT / Interest Expense | 11.54 | 28.56 | 49.77 | 20.95 | 20.6 | |||||
EBITDA / Interest Expense | 15.99 | 35.8 | 62.18 | 26.3 | 25.83 | |||||
(EBITDA - Capex) / Interest Expense | 13.9 | 30.18 | 51.68 | 21.68 | 19.61 | |||||
Total Debt / EBITDA | 0.69 | 0.46 | 0.42 | 0.52 | 1.09 | |||||
Net Debt / EBITDA | -0.42 | -0.36 | -0.36 | -0.24 | 0.55 | |||||
Total Debt / (EBITDA - Capex) | 0.79 | 0.54 | 0.51 | 0.64 | 1.44 | |||||
Net Debt / (EBITDA - Capex) | -0.48 | -0.42 | -0.44 | -0.29 | 0.73 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.44 | 13.89 | 14.31 | 2.53 | 12.07 | |||||
Gross Profit, 1 Yr. Growth % | -0.96 | 15.43 | 12.79 | 2.27 | 15.77 | |||||
EBITDA, 1 Yr. Growth % | 8.22 | 28.05 | 7.82 | 1.72 | 23.06 | |||||
EBITA, 1 Yr. Growth % | 9.9 | 33.18 | 8.19 | 1.17 | 23.15 | |||||
EBIT, 1 Yr. Growth % | 18 | 40.28 | 8.54 | 1.31 | 23.07 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 160.5 | -17.57 | 4.86 | -0.17 | 20.39 | |||||
Net Income, 1 Yr. Growth % | 166.66 | -16.82 | 7.78 | -0.53 | 19.78 | |||||
Normalized Net Income, 1 Yr. Growth % | 33.16 | 51.25 | 16.13 | -2.82 | 23.94 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 166.61 | -16.9 | 7.85 | -0.28 | 20.58 | |||||
Accounts Receivable, 1 Yr. Growth % | 2.32 | 5.58 | 36.25 | 14.82 | 16.73 | |||||
Inventory, 1 Yr. Growth % | 2.16 | 28.1 | 22.41 | 2.65 | 18.99 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.53 | 7.16 | 7.46 | 9.34 | 44.34 | |||||
Total Assets, 1 Yr. Growth % | -16.01 | 8.3 | 10.98 | 9.16 | 26.98 | |||||
Tangible Book Value, 1 Yr. Growth % | -606.5 | 27.78 | 23.91 | 1.79 | -6.29 | |||||
Common Equity, 1 Yr. Growth % | 20.31 | 16.74 | 15.78 | 7.22 | 15.86 | |||||
Cash From Operations, 1 Yr. Growth % | -8.14 | 9.24 | -23.8 | 19.86 | 72.13 | |||||
Capital Expenditures, 1 Yr. Growth % | 34.34 | 49.84 | 15.13 | 5.93 | 68.72 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -6.12 | -20.67 | -51.95 | 54.89 | 32.61 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -9.54 | -22.25 | -51.28 | 60.32 | 31.91 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 66.67 | 5.6 | 0 | 9.85 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.69 | 6.48 | 14.1 | 8.26 | 7.19 | |||||
Gross Profit, 2 Yr. CAGR % | 3.67 | 6.92 | 13.46 | 7.4 | 8.81 | |||||
EBITDA, 2 Yr. CAGR % | 17.05 | 16.99 | 17.04 | 4.73 | 12.12 | |||||
EBITA, 2 Yr. CAGR % | 20.53 | 20.11 | 19.5 | 4.62 | 11.62 | |||||
EBIT, 2 Yr. CAGR % | 28.4 | 27.66 | 22.81 | 4.86 | 11.66 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 159.92 | 45.8 | -7.02 | 2.31 | 9.63 | |||||
Net Income, 2 Yr. CAGR % | 161.52 | 48.16 | -5.31 | 3.53 | 9.15 | |||||
Normalized Net Income, 2 Yr. CAGR % | 46.12 | 40.64 | 31.86 | 6.23 | 9.75 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 161.27 | 48.07 | -5.39 | 3.67 | 9.66 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.09 | 3.94 | 19.94 | 25.08 | 15.77 | |||||
Inventory, 2 Yr. CAGR % | 3.82 | 14.39 | 25.22 | 12.09 | 10.52 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.55 | -0.52 | 7.31 | 8.4 | 25.63 | |||||
Total Assets, 2 Yr. CAGR % | -6.55 | -4.71 | 9.63 | 10.07 | 17.73 | |||||
Tangible Book Value, 2 Yr. CAGR % | 53.56 | 154.55 | 25.83 | 12.34 | -2.33 | |||||
Common Equity, 2 Yr. CAGR % | 16.33 | 18.32 | 16.26 | 11.44 | 11.46 | |||||
Cash From Operations, 2 Yr. CAGR % | 20.24 | -0.65 | -8.77 | -4.43 | 43.64 | |||||
Capital Expenditures, 2 Yr. CAGR % | -6.74 | 41.88 | 31.34 | 10.44 | 33.69 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 51.43 | -13.46 | -38.91 | -14.4 | 43.63 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 38.83 | -15.91 | -39.07 | -12.26 | 45.7 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | 32.66 | 2.76 | 4.81 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.72 | 6.98 | 9.03 | 10.1 | 9.51 | |||||
Gross Profit, 3 Yr. CAGR % | 3.41 | 7.45 | 8.43 | 9.6 | 10.12 | |||||
EBITDA, 3 Yr. CAGR % | 14.55 | 20.11 | 13.56 | 11.7 | 10.67 | |||||
EBITA, 3 Yr. CAGR % | 17.4 | 24 | 15.65 | 13.05 | 10.46 | |||||
EBIT, 3 Yr. CAGR % | 23.97 | 31.56 | 20.56 | 15.18 | 10.61 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 331.96 | 76.66 | 30.63 | -4.8 | 8.01 | |||||
Net Income, 3 Yr. CAGR % | 276.53 | 77.9 | 33.25 | -3.75 | 8.69 | |||||
Normalized Net Income, 3 Yr. CAGR % | 37.6 | 46.92 | 31.5 | 19.11 | 11.84 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 274.56 | 77.72 | 33.17 | -3.74 | 9.03 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.44 | 1.89 | 13.75 | 18.21 | 22.23 | |||||
Inventory, 3 Yr. CAGR % | 4.53 | 11.36 | 17.01 | 17.19 | 14.35 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.07 | 2.67 | 2.07 | 7.98 | 19.26 | |||||
Total Assets, 3 Yr. CAGR % | -4.53 | -1.9 | 0.26 | 9.48 | 15.44 | |||||
Tangible Book Value, 3 Yr. CAGR % | 23.45 | 44.49 | 100.24 | 17.27 | 5.75 | |||||
Common Equity, 3 Yr. CAGR % | 12.6 | 16.35 | 17.47 | 13.18 | 12.9 | |||||
Cash From Operations, 3 Yr. CAGR % | 3.89 | 15.82 | -9.06 | -0.08 | 16.28 | |||||
Capital Expenditures, 3 Yr. CAGR % | -10.7 | 9.23 | 32.34 | 22.26 | 27.19 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.39 | 22.3 | -29.37 | -17.13 | -0.81 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 10.81 | 14.64 | -30.37 | -16.29 | 0.64 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | 20.74 | 5.07 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.84 | 4.06 | 7.13 | 7.49 | 8.29 | |||||
Gross Profit, 5 Yr. CAGR % | 2.17 | 4.51 | 7.32 | 7.19 | 8.58 | |||||
EBITDA, 5 Yr. CAGR % | 13.76 | 13.26 | 15.25 | 13.53 | 12.98 | |||||
EBITA, 5 Yr. CAGR % | 17 | 15.56 | 17.89 | 15.65 | 14.02 | |||||
EBIT, 5 Yr. CAGR % | 26.04 | 20.83 | 23.12 | 19.92 | 16.92 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 62.1 | 25.03 | 133.2 | 41.98 | 21.78 | |||||
Net Income, 5 Yr. CAGR % | 70.99 | 26.71 | 116.32 | 43.26 | 23.03 | |||||
Normalized Net Income, 5 Yr. CAGR % | 50.63 | 28.63 | 34.79 | 28.79 | 22.32 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 70.95 | 26.66 | 115.57 | 43.22 | 23.2 | |||||
Accounts Receivable, 5 Yr. CAGR % | -7.59 | -3.63 | 5.31 | 10.6 | 14.56 | |||||
Inventory, 5 Yr. CAGR % | 2.97 | 6.44 | 12.36 | 11.65 | 14.37 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 0.88 | 0.74 | 2.88 | 4.92 | 10.91 | |||||
Total Assets, 5 Yr. CAGR % | -4.92 | -3.25 | 0.86 | 2.72 | 6.91 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.72 | 14.32 | 24.42 | 30.65 | 50.27 | |||||
Common Equity, 5 Yr. CAGR % | 7.28 | 8.89 | 13.98 | 14.36 | 15.04 | |||||
Cash From Operations, 5 Yr. CAGR % | 21.2 | -1.83 | -1.69 | 7.25 | 9.18 | |||||
Capital Expenditures, 5 Yr. CAGR % | -9.51 | -0.43 | 4.2 | 9.71 | 32.88 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 35 | -3.14 | -10.42 | 5.59 | -6.47 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 53.89 | -4.8 | -12.67 | 2.59 | -6.72 |
- Stock Market
- Equities
- VIRP Stock
- Financials Virbac
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions